These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16700748)

  • 1. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome.
    Boras VV; Brailo V; Lukac J; Kordić D; Blazić-Potocki Z
    Oral Dis; 2006 May; 12(3):353-5. PubMed ID: 16700748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
    Suh KI; Kim YK; Kho HS
    Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines.
    Pekiner FN; Gümrü B; Demirel GY; Ozbayrak S
    J Oral Pathol Med; 2009 Mar; 38(3):269-75. PubMed ID: 19141055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration.
    Boras VV; Lukac J; Brailo V; Picek P; Kordić D; Zilić IA
    J Oral Pathol Med; 2006 Apr; 35(4):241-3. PubMed ID: 16519772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary interleukin-6 and tumor necrosis factor alpha in patients with drug-induced xerostomia.
    Vucićević Boras V; Brailo V; Lukac J; Kordić D; Picek P; Blazic-Potocki Z
    Oral Dis; 2006 Sep; 12(5):509-11. PubMed ID: 16910924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
    Brailo V; Vucićević-Boras V; Cekić-Arambasin A; Alajbeg IZ; Milenović A; Lukac J
    Oral Oncol; 2006 Apr; 42(4):370-3. PubMed ID: 16324876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burning mouth syndrome: a therapeutic approach involving mechanical salivary stimulation.
    de Souza FT; Amaral TM; dos Santos TP; Abdo EN; Aguiar MC; Teixeira AL; Kummer AM; Abreu MH; Silva TA
    Headache; 2012 Jun; 52(6):1026-34. PubMed ID: 22084903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome.
    Pekiner FN; Demirel GY; Gümrü B; Ozbayrak S
    J Oral Pathol Med; 2008 Oct; 37(9):528-34. PubMed ID: 18624934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of total IgE in unspecified burning oral symptoms. Serum and salivary comparative levels in a case-control study].
    Campisi G; Di Liberto C
    Minerva Stomatol; 2003; 52(7-8):381-91. PubMed ID: 14608259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma.
    SahebJamee M; Eslami M; AtarbashiMoghadam F; Sarafnejad A
    Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E292-5. PubMed ID: 18449112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile.
    de Moura SA; de Sousa JM; Lima DF; Negreiros AN; Silva Fde V; da Costa LJ
    Gerodontology; 2007 Sep; 24(3):173-6. PubMed ID: 17696895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral burning symptoms and burning mouth syndrome-significance of different variables in 150 patients.
    Brailo V; Vuéiaeeviae-Boras V; Alajbeg IZ; Alajbeg I; Lukenda J; Aeurkoviae M
    Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E252-5. PubMed ID: 16648763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
    Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
    Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study.
    Amenábar JM; Pawlowski J; Hilgert JB; Hugo FN; Bandeira D; Lhüller F; Lopes de Souza MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):460-5. PubMed ID: 18329582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study.
    Borelli V; Marchioli A; Di Taranto R; Romano M; Chiandussi S; Di Lenarda R; Biasotto M; Zabucchi G
    Oral Dis; 2010 May; 16(4):365-74. PubMed ID: 20233324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome].
    Xia J; Lin M; Jin Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Oct; 21(5):377-8. PubMed ID: 14650995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burning mouth syndrome and personality profiles.
    Merigo E; Manfredi M; Zanetti MR; Miazza D; Pedrazzi G; Vescovi P
    Minerva Stomatol; 2007 Apr; 56(4):159-67. PubMed ID: 17452954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone.
    Rhodus NL; Cheng B; Bowles W; Myers S; Miller L; Ondrey F
    Oral Dis; 2006 Mar; 12(2):112-6. PubMed ID: 16476030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.